Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms. | Sci Rep | 2024 | 38308077 | PubTator, text mining | PubMed |
| Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38307969 | PubTator, text mining | PubMed |
| Exploring the untapped pharmacological potential of imidazopyridazines. | RSC Adv | 2024 | 38288152 | PubTator, text mining | PubMed |
| Seize the engine: Emerging cell cycle targets in breast cancer. | Clin Transl Med | 2024 | 38264947 | PubTator, text mining | PubMed |
| Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner. | Antioxidants (Basel) | 2024 | 38247509 | PubTator, text mining | PubMed |
| Strategies to overcome low MHC-I expression in paediatric and adult tumours. | Immunother Adv | 2024 | 38223409 | PubTator, text mining | PubMed |
| Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients. | Cancer Cell Int | 2024 | 38195567 | PubTator, text mining | PubMed |
| FTHL17, PRM2, CABYR, CPXCR1, ADAM29, and CABS1 are highly expressed in colon cancer patients and are regulated in vitro by epigenetic alterations. | Heliyon | 2024 | 38187237 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population. | Hum Genet | 2024 | 38182908 | PubTator, text mining | PubMed |
| MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer. | Aging (Albany NY) | 2024 | 38180746 | PubTator, text mining | PubMed |
| Identification of genes and pathways associated with menopausal status in breast cancer patients using two algorithms. | BMC Womens Health | 2024 | 38166892 | PubTator, text mining | PubMed |
| Fission yeast Wee1 is required for stable kinetochore-microtubule attachment. | Open Biol | 2024 | 38166399 | PubTator, text mining | PubMed |
| Dicentric chromosomes are resolved through breakage and repair at their centromeres. | Chromosoma | 2024 | 38165460 | PubTator, text mining | PubMed |
| Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor. | Bioorg Chem | 2024 | 38159497 | PubTator, text mining | PubMed |
| Toll-like receptor agonists as cancer vaccine adjuvants. | Hum Vaccin Immunother | 2024 | 38155525 | PubTator, text mining | PubMed |
| B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations. | Proc Natl Acad Sci U S A | 2024 | 38150499 | PubTator, text mining | PubMed |
| Age-dependent loss of cohesion protection in human oocytes. | Curr Biol | 2024 | 38134935 | PubTator, text mining | PubMed |
| Phosphorylation of Bub1 by Mph1 promotes Bub1 signaling at the kinetochore to ensure accurate chromosome segregation. | J Biol Chem | 2024 | 38097187 | PubTator, text mining | PubMed |
| Prognostic value of lncRNA AFAP1-AS1 in breast cancer: a meta-analysis and validated study in Chinese population. | Cancer Rep (Hoboken) | 2024 | 37916733 | PubTator, text mining | PubMed |
| In-vitro Antioxidant, In-vitro and In-silico Ovarian Anticancer Activity (Ovarian Cancer Cells-PA1) and Phytochemical Analysis of Cissus quadrangularis L. Ethanolic Extract. | Comb Chem High Throughput Screen | 2024 | 37818574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=12